NFE2L2 is detected as a mutational cancer driver in Esophageal Adenocarcinoma
NFE2L2 reports in Esophageal Adenocarcinoma (ESCA)
Cancer type details
Esophageal Adenocarcinoma |
---|
Cohorts
8
Samples 1,139 Mutations 17,905,104 Driver genes 90 |
Gene details
NFE2L2 |
---|
Ensembl ID
ENSG00000116044
Transcript ID ENST00000397062 Protein ID ENSP00000380252 |
Cohorts where is driver
1
Mutated samples 17 Mutated samples (%) 1.49 Mutations 32 |
Mode of action Activating |
Known driver True |
Method signals per Cohort
Cohort | Methods | Samples | Samples (%) |
---|
In-silico saturation mutagenesis
Model | Mutations | Driver mutations | Driver mutations (%) |
---|---|---|---|
ESCA (Esophageal Adenocarcinoma) | 5436 | 140 | 2.58 |
Observed mutations in tumors
Mutation (GRCh38) | Protein Position | Samples | Samples (%) | Consequence | Driver | Driver score |
---|